Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Cough/Cold Resumes Line Extension, Launch Activity

This article was originally published in The Tan Sheet

Executive Summary

Firms are returning to line extension activity for iconic brands such Alka-Seltzer, Robitussin, Triaminic and Vicks, some with OTC monograph ingredients added to provide new indications. Market researchers project category growth through 2014 and discuss factors affecting cough/cold product sales.

You may also be interested in...



Regulatory News In Brief

FDA, FTC shoot down GermBullet claims; Emu products cited for disease claims; Novartis cough/cold recall in Canada; Super Power spiked with sildenafil; more Regulatory News In Brief.

Infirst Expects Dr. Cocoa OTCs To Win Over Children And Parents

CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.

Infirst Expects Dr. Cocoa OTCs To Win Over Children And Parents

CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel